{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,27]],"date-time":"2026-09-27T05:45:15Z","timestamp":1790487915645,"version":"4.1.0"},"reference-count":168,"publisher":"Elsevier BV","issue":"5","license":[{"start":{"date-parts":[[2016,5,1]],"date-time":"2016-05-01T00:00:00Z","timestamp":1462060800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"funder":[{"DOI":"10.13039\/100000054","name":"National Cancer Institute","doi-asserted-by":"publisher","award":["R01CA154835"],"award-info":[{"award-number":["R01CA154835"]}],"id":[{"id":"10.13039\/100000054","id-type":"DOI","asserted-by":"publisher"}]},{"name":"UNCF\/Merck Postdoctoral Science Research Fellowship (J.C.Z.)"},{"DOI":"10.13039\/100006019","name":"Van Andel Research Institute","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100006019","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Cellular Signalling"],"published-print":{"date-parts":[[2016,5]]},"DOI":"10.1016\/j.cellsig.2016.01.013","type":"journal-article","created":{"date-parts":[[2016,1,29]],"date-time":"2016-01-29T05:10:56Z","timestamp":1454044256000},"page":"348-356","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":53,"title":["The importance of non-nuclear AR signaling in prostate cancer progression and therapeutic resistance"],"prefix":"10.1016","volume":"28","author":[{"given":"Jelani C.","family":"Zarif","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cindy K.","family":"Miranti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.cellsig.2016.01.013_bb0005","doi-asserted-by":"crossref","first-page":"5","DOI":"10.3322\/caac.21254","article-title":"Cancer statistics, 2015","volume":"65","author":"Siegel","year":"2015","journal-title":"CA Cancer J. Clin."},{"key":"10.1016\/j.cellsig.2016.01.013_bb0010","doi-asserted-by":"crossref","first-page":"300","DOI":"10.3322\/canjclin.55.5.300","article-title":"Advances in prostate cancer chemotherapy: a new era begins","volume":"55","author":"Pienta","year":"2005","journal-title":"CA Cancer J. Clin."},{"key":"10.1016\/j.cellsig.2016.01.013_bb0015","doi-asserted-by":"crossref","first-page":"401","DOI":"10.1038\/ng0495-401","article-title":"In vivo amplification of the androgen receptor gene and progression of human prostate cancer","volume":"9","author":"Visakorpi","year":"1995","journal-title":"Nat. Genet."},{"key":"10.1016\/j.cellsig.2016.01.013_bb0020","doi-asserted-by":"crossref","first-page":"3001","DOI":"10.1200\/JCO.2002.10.018","article-title":"Molecular biology of the androgen receptor","volume":"20","author":"Gelmann","year":"2002","journal-title":"J. Clin. Oncol."},{"key":"10.1016\/j.cellsig.2016.01.013_bb0025","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1038\/nm972","article-title":"Molecular determinants of resistance to antiandrogen therapy","volume":"10","author":"Chen","year":"2004","journal-title":"Nat. Med."},{"key":"10.1016\/j.cellsig.2016.01.013_bb0030","doi-asserted-by":"crossref","first-page":"1437","DOI":"10.1016\/S0140-6736(10)60172-9","article-title":"C. Prostate Cancer Foundation\/Department of Defense Prostate Cancer clinical trials, antitumour activity of MDV3100 in castration-resistant prostate cancer: a phase 1\u20132 study","volume":"375","author":"Scher","year":"2010","journal-title":"Lancet"},{"key":"10.1016\/j.cellsig.2016.01.013_bb0035","doi-asserted-by":"crossref","first-page":"2767","DOI":"10.1093\/nar\/gkm198","article-title":"A promoting role of androgen receptor in androgen-sensitive and -insensitive prostate cancer cells","volume":"35","author":"Li","year":"2007","journal-title":"Nucleic Acids Res."},{"key":"10.1016\/j.cellsig.2016.01.013_bb0040","doi-asserted-by":"crossref","first-page":"505","DOI":"10.1158\/1535-7163.MCT-04-0313","article-title":"Small-interfering RNA-induced androgen receptor silencing leads to apoptotic cell death in prostate cancer","volume":"4","author":"Liao","year":"2005","journal-title":"Mol. Cancer Ther."},{"key":"10.1016\/j.cellsig.2016.01.013_bb0045","doi-asserted-by":"crossref","first-page":"363","DOI":"10.1002\/jcb.22022","article-title":"Mechanisms of prostate cancer cell survival after inhibition of AR expression","volume":"106","author":"Cohen","year":"2009","journal-title":"J. Cell. Biochem."},{"key":"10.1016\/j.cellsig.2016.01.013_bb0050","doi-asserted-by":"crossref","first-page":"1028","DOI":"10.1056\/NEJMoa1315815","article-title":"AR-V7 and resistance to enzalutamide and abiraterone in prostate cancer","volume":"371","author":"Antonarakis","year":"2014","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.cellsig.2016.01.013_bb0055","doi-asserted-by":"crossref","first-page":"1335","DOI":"10.1158\/1078-0432.CCR-12-2910","article-title":"Enzalutamide: a novel antiandrogen for patients with castrate-resistant prostate cancer","volume":"19","author":"Hoffman-Censits","year":"2013","journal-title":"Clin. Cancer Res."},{"key":"10.1016\/j.cellsig.2016.01.013_bb0060","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1016\/j.eururo.2014.05.005","article-title":"Molecular characterization of enzalutamide-treated bone metastatic castration-resistant prostate cancer","volume":"67","author":"Efstathiou","year":"2015","journal-title":"Eur. Urol."},{"key":"10.1016\/j.cellsig.2016.01.013_bb0065","doi-asserted-by":"crossref","first-page":"6862","DOI":"10.18632\/oncotarget.3119","article-title":"Androgen receptor non-nuclear regulation of prostate cancer cell invasion mediated by Src and matriptase","volume":"6","author":"Zarif","year":"2015","journal-title":"Oncotarget"},{"key":"10.1016\/j.cellsig.2016.01.013_bb0070","doi-asserted-by":"crossref","first-page":"5406","DOI":"10.1093\/emboj\/19.20.5406","article-title":"Steroid-induced androgen receptor\u2013oestradiol receptor beta\u2013Src complex triggers prostate cancer cell proliferation","volume":"19","author":"Migliaccio","year":"2000","journal-title":"EMBO J."},{"key":"10.1016\/j.cellsig.2016.01.013_bb0075","doi-asserted-by":"crossref","first-page":"1587","DOI":"10.3892\/ijo.2012.1593","article-title":"Epidermal growth factor induces bladder cancer cell proliferation through activation of the androgen receptor","volume":"41","author":"Izumi","year":"2012","journal-title":"Int. J. Oncol."},{"key":"10.1016\/j.cellsig.2016.01.013_bb0080","doi-asserted-by":"crossref","first-page":"1030","DOI":"10.1158\/2159-8290.CD-13-0142","article-title":"An F876L mutation in androgen receptor confers genetic and phenotypic resistance to MDV3100 (enzalutamide)","volume":"3","author":"Korpal","year":"2013","journal-title":"Cancer Discov."},{"key":"10.1016\/j.cellsig.2016.01.013_bb0085","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1016\/S0083-6729(01)62005-3","article-title":"Androgen receptors and their biology","volume":"62","author":"Lamb","year":"2001","journal-title":"Vitam. Horm."},{"key":"10.1016\/j.cellsig.2016.01.013_bb0090","doi-asserted-by":"crossref","first-page":"2855","DOI":"10.1210\/me.2007-0223","article-title":"Androgen receptor structural and functional elements: role and regulation in prostate cancer","volume":"21","author":"Dehm","year":"2007","journal-title":"Mol. Endocrinol."},{"key":"10.1016\/j.cellsig.2016.01.013_bb0095","doi-asserted-by":"crossref","first-page":"2972","DOI":"10.1210\/jc.2002-022038","article-title":"Is the Achilles' heel for prostate cancer therapy a gain of function in androgen receptor signaling?","volume":"88","author":"Litvinov","year":"2003","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"10.1016\/j.cellsig.2016.01.013_bb0100","doi-asserted-by":"crossref","first-page":"362","DOI":"10.1002\/jcb.20811","article-title":"Androgen receptor action in hormone-dependent and recurrent prostate cancer","volume":"99","author":"Agoulnik","year":"2006","journal-title":"J. Cell. Biochem."},{"key":"10.1016\/j.cellsig.2016.01.013_bb0105","doi-asserted-by":"crossref","first-page":"733","DOI":"10.1038\/42750","article-title":"A signature motif in transcriptional co-activators mediates binding to nuclear receptors","volume":"387","author":"Heery","year":"1997","journal-title":"Nature"},{"key":"10.1016\/j.cellsig.2016.01.013_bb0110","doi-asserted-by":"crossref","first-page":"778","DOI":"10.1210\/er.2007-0019","article-title":"Androgen receptor (AR) coregulators: a diversity of functions converging on and regulating the AR transcriptional complex","volume":"28","author":"Heemers","year":"2007","journal-title":"Endocr. Rev."},{"key":"10.1016\/j.cellsig.2016.01.013_bb0115","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1038\/352077a0","article-title":"Androgen receptor gene mutations in X-linked spinal and bulbar muscular atrophy","volume":"352","author":"La Spada","year":"1991","journal-title":"Nature"},{"key":"10.1016\/j.cellsig.2016.01.013_bb0120","doi-asserted-by":"crossref","first-page":"3320","DOI":"10.1073\/pnas.94.7.3320","article-title":"The CAG repeat within the androgen receptor gene and its relationship to prostate cancer","volume":"94","author":"Giovannucci","year":"1997","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"issue":"Pt 3","key":"10.1016\/j.cellsig.2016.01.013_bb0125","doi-asserted-by":"crossref","first-page":"761","DOI":"10.1042\/bj2930761","article-title":"Nuclear import of the human androgen receptor","volume":"293","author":"Jenster","year":"1993","journal-title":"Biochem. J."},{"key":"10.1016\/j.cellsig.2016.01.013_bb0130","doi-asserted-by":"crossref","first-page":"13115","DOI":"10.1016\/S0021-9258(17)36806-0","article-title":"A ligand-dependent bipartite nuclear targeting signal in the human androgen receptor. Requirement for the DNA-binding domain and modulation by NH2-terminal and carboxyl-terminal sequences","volume":"269","author":"Zhou","year":"1994","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.cellsig.2016.01.013_bb0135","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1016\/S0960-0760(00)00154-0","article-title":"Selective DNA binding by the androgen receptor as a mechanism for hormone-specific gene regulation","volume":"76","author":"Claessens","year":"2001","journal-title":"J. Steroid Biochem. Mol. Biol."},{"key":"10.1016\/j.cellsig.2016.01.013_bb0140","doi-asserted-by":"crossref","first-page":"2943","DOI":"10.1074\/jbc.M009170200","article-title":"Two classes of androgen receptor elements mediate cooperativity through allosteric interactions","volume":"276","author":"Reid","year":"2001","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.cellsig.2016.01.013_bb0145","doi-asserted-by":"crossref","first-page":"871","DOI":"10.1038\/sj.embor.7401046","article-title":"New androgen receptor genomic targets show an interaction with the ETS1 transcription factor","volume":"8","author":"Massie","year":"2007","journal-title":"EMBO Rep."},{"key":"10.1016\/j.cellsig.2016.01.013_bb0150","doi-asserted-by":"crossref","first-page":"1327","DOI":"10.1002\/1615-9861(200110)1:10<1327::AID-PROT1327>3.0.CO;2-B","article-title":"Identification of androgen-regulated genes in the prostate cancer cell line LNCaP by serial analysis of gene expression and proteomic analysis","volume":"1","author":"Waghray","year":"2001","journal-title":"Proteomics"},{"key":"10.1016\/j.cellsig.2016.01.013_bb0155","doi-asserted-by":"crossref","first-page":"327","DOI":"10.1016\/S0968-0004(96)10050-5","article-title":"The role of general initiation factors in transcription by RNA polymerase II","volume":"21","author":"Roeder","year":"1996","journal-title":"Trends Biochem. Sci."},{"key":"10.1016\/j.cellsig.2016.01.013_bb0160","doi-asserted-by":"crossref","first-page":"2410","DOI":"10.1101\/gad.819500","article-title":"Molecular genetics of prostate cancer","volume":"14","author":"Abate-Shen","year":"2000","journal-title":"Genes Dev."},{"key":"10.1016\/j.cellsig.2016.01.013_bb0165","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1038\/35094009","article-title":"The development of androgen-independent prostate cancer","volume":"1","author":"Feldman","year":"2001","journal-title":"Nat. Rev. Cancer"},{"key":"10.1016\/j.cellsig.2016.01.013_bb0170","doi-asserted-by":"crossref","first-page":"266","DOI":"10.1242\/jcs.054502","article-title":"E-cadherin-mediated survival of androgen-receptor-expressing secretory prostate epithelial cells derived from a stratified in vitro differentiation model","volume":"123","author":"Lamb","year":"2010","journal-title":"J. Cell Sci."},{"key":"10.1016\/j.cellsig.2016.01.013_bb0175","doi-asserted-by":"crossref","first-page":"12679","DOI":"10.1073\/pnas.0704940104","article-title":"Increased prostate cell proliferation and loss of cell differentiation in mice lacking prostate epithelial androgen receptor","volume":"104","author":"Wu","year":"2007","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.cellsig.2016.01.013_bb0180","doi-asserted-by":"crossref","first-page":"342","DOI":"10.1002\/jemt.1070300409","article-title":"Analysis of cell death and cell proliferation in embryonic stages, normal adult, and aging prostates in human and animals","volume":"30","author":"Sensibar","year":"1995","journal-title":"Microsc. Res. Tech."},{"key":"10.1016\/j.cellsig.2016.01.013_bb0185","first-page":"35","article-title":"Androgen action in the prostate gland","volume":"64","author":"Yadav","year":"2012","journal-title":"Minerva Urol. Nefrol."},{"key":"10.1016\/j.cellsig.2016.01.013_bb0190","doi-asserted-by":"crossref","first-page":"12182","DOI":"10.1073\/pnas.0804700105","article-title":"Androgen receptor is a tumor suppressor and proliferator in prostate cancer","volume":"105","author":"Niu","year":"2008","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.cellsig.2016.01.013_bb0195","first-page":"1","article-title":"Androgen induction of in vitro prostate cell differentiation","volume":"13","author":"Whitacre","year":"2002","journal-title":"Cell Growth Differ."},{"key":"10.1016\/j.cellsig.2016.01.013_bb0200","doi-asserted-by":"crossref","first-page":"8867","DOI":"10.1158\/0008-5472.CAN-04-2938","article-title":"Androgen-induced differentiation and tumorigenicity of human prostate epithelial cells","volume":"64","author":"Berger","year":"2004","journal-title":"Cancer Res."},{"key":"10.1016\/j.cellsig.2016.01.013_bb0205","doi-asserted-by":"crossref","first-page":"12827","DOI":"10.1074\/jbc.274.18.12827","article-title":"Fibroblast growth factor-10. A second candidate stromal to epithelial cell andromedin in prostate","volume":"274","author":"Lu","year":"1999","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.cellsig.2016.01.013_bb0210","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1002\/(SICI)1097-0045(19991201)41:4<233::AID-PROS3>3.0.CO;2-L","article-title":"Immunolocalization of the keratinocyte growth factor in benign and neoplastic human prostate and its relation to androgen receptor","volume":"41","author":"Planz","year":"1999","journal-title":"Prostate"},{"key":"10.1016\/j.cellsig.2016.01.013_bb0215","first-page":"3663","article-title":"Keratin immunoreactivity in the benign and neoplastic human prostate","volume":"45","author":"Brawer","year":"1985","journal-title":"Cancer Res."},{"key":"10.1016\/j.cellsig.2016.01.013_bb0220","first-page":"281","article-title":"Cytokeratin characterization of human prostatic carcinoma and its derived cell lines","volume":"47","author":"Nagle","year":"1987","journal-title":"Cancer Res."},{"key":"10.1016\/j.cellsig.2016.01.013_bb0225","doi-asserted-by":"crossref","first-page":"3357","DOI":"10.1158\/0008-5472.CAN-13-3076","article-title":"Transient induction of ING4 by Myc drives prostate epithelial cell differentiation and its disruption drives prostate tumorigenesis","volume":"74","author":"Berger","year":"2014","journal-title":"Cancer Res."},{"key":"10.1016\/j.cellsig.2016.01.013_bb0230","doi-asserted-by":"crossref","first-page":"e15","DOI":"10.1016\/j.urolonc.2013.08.025","article-title":"The prostate cancer genome: perspectives and potential","volume":"32","author":"Barbieri","year":"2014","journal-title":"Urol. Oncol."},{"key":"10.1016\/j.cellsig.2016.01.013_bb0235","doi-asserted-by":"crossref","first-page":"644","DOI":"10.1126\/science.1117679","article-title":"Recurrent fusion of TMPRSS2 and ETS transcription factor genes in prostate cancer","volume":"310","author":"Tomlins","year":"2005","journal-title":"Science"},{"key":"10.1016\/j.cellsig.2016.01.013_bb0240","doi-asserted-by":"crossref","first-page":"5693","DOI":"10.1093\/nar\/gkh906","article-title":"Expression profiles frame the promoter specificity dilemma of the ETS family of transcription factors","volume":"32","author":"Hollenhorst","year":"2004","journal-title":"Nucleic Acids Res."},{"key":"10.1016\/j.cellsig.2016.01.013_bb0245","doi-asserted-by":"crossref","first-page":"437","DOI":"10.1146\/annurev.biochem.79.081507.103945","article-title":"Genomic and biochemical insights into the specificity of ETS transcription factors","volume":"80","author":"Hollenhorst","year":"2011","journal-title":"Annu. Rev. Biochem."},{"key":"10.1016\/j.cellsig.2016.01.013_bb0250","doi-asserted-by":"crossref","first-page":"1044","DOI":"10.1177\/1947601910395578","article-title":"The ETS gene ETV4 is required for anchorage-independent growth and a cell proliferation gene expression program in PC3 prostate cells","volume":"1","author":"Hollenhorst","year":"2011","journal-title":"Genes Cancer"},{"key":"10.1016\/j.cellsig.2016.01.013_bb0255","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1007\/978-1-61779-243-4_15","article-title":"Global identification of androgen response elements","volume":"776","author":"Massie","year":"2011","journal-title":"Methods Mol. Biol."},{"key":"10.1016\/j.cellsig.2016.01.013_bb0260","doi-asserted-by":"crossref","first-page":"2719","DOI":"10.1038\/emboj.2011.158","article-title":"The androgen receptor fuels prostate cancer by regulating central metabolism and biosynthesis","volume":"30","author":"Massie","year":"2011","journal-title":"EMBO J."},{"key":"10.1016\/j.cellsig.2016.01.013_bb0265","doi-asserted-by":"crossref","first-page":"1899","DOI":"10.1172\/JCI112185","article-title":"A kallikrein-like serine protease in prostatic fluid cleaves the predominant seminal vesicle protein","volume":"76","author":"Lilja","year":"1985","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.cellsig.2016.01.013_bb0270","doi-asserted-by":"crossref","first-page":"120","DOI":"10.7326\/0003-4819-157-2-201207170-00459","article-title":"U.S.P.S.T. Force, screening for prostate cancer: U.S. Preventive Services Task Force recommendation statement","volume":"157","author":"Moyer","year":"2012","journal-title":"Ann. Intern. Med."},{"key":"10.1016\/j.cellsig.2016.01.013_bb0275","doi-asserted-by":"crossref","first-page":"1241","DOI":"10.1111\/j.1464-410X.2005.05821.x","article-title":"Selective blockade of androgenic steroid synthesis by novel lyase inhibitors as a therapeutic strategy for treating metastatic prostate cancer","volume":"96","author":"Attard","year":"2005","journal-title":"BJU Int."},{"key":"10.1016\/j.cellsig.2016.01.013_bb0280","doi-asserted-by":"crossref","first-page":"80","DOI":"10.1016\/j.jsbmb.2012.10.020","article-title":"Effect of a novel 17,20-lyase inhibitor, orteronel (TAK-700), on androgen synthesis in male rats","volume":"134","author":"Hara","year":"2013","journal-title":"J. Steroid Biochem. Mol. Biol."},{"key":"10.1016\/j.cellsig.2016.01.013_bb0285","doi-asserted-by":"crossref","first-page":"3777","DOI":"10.1074\/jbc.M111.261933","article-title":"Direct regulation of androgen receptor activity by potent CYP17 inhibitors in prostate cancer cells","volume":"287","author":"Soifer","year":"2012","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.cellsig.2016.01.013_bb0290","doi-asserted-by":"crossref","first-page":"298","DOI":"10.1016\/j.jsbmb.2013.07.002","article-title":"Effect of an investigational CYP17A1 inhibitor, orteronel (TAK-700), on estrogen- and corticoid-synthesis pathways in hypophysectomized female rats and on the serum estradiol levels in female cynomolgus monkeys","volume":"138","author":"Yamaoka","year":"2013","journal-title":"J. Steroid Biochem. Mol. Biol."},{"key":"10.1016\/j.cellsig.2016.01.013_bb0295","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1158\/1535-7163.MCT-14-0521","article-title":"Anticancer activity of a novel selective CYP17A1 inhibitor in preclinical models of castrate-resistant prostate cancer","volume":"14","author":"Toren","year":"2015","journal-title":"Mol. Cancer Ther."},{"key":"10.1016\/j.cellsig.2016.01.013_bb0300","doi-asserted-by":"crossref","first-page":"4319","DOI":"10.1158\/1078-0432.CCR-10-0255","article-title":"Overcoming persistent dependency on androgen signaling after progression to castration-resistant prostate cancer","volume":"16","author":"Yamaoka","year":"2010","journal-title":"Clin. Cancer Res."},{"key":"10.1016\/j.cellsig.2016.01.013_bb0305","doi-asserted-by":"crossref","first-page":"5261","DOI":"10.1016\/j.bmc.2013.06.025","article-title":"Discovery of 2-methyl-1-{1-[(5-methyl-1H-indol-2-yl)carbonyl]piperidin-4-yl}propan-2-ol: a novel, potent and selective type 5 17beta-hydroxysteroid dehydrogenase inhibitor","volume":"21","author":"Watanabe","year":"2013","journal-title":"Bioorg. Med. Chem."},{"key":"10.1016\/j.cellsig.2016.01.013_bb0310","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1016\/0303-7207(92)90004-P","article-title":"Testosterone and 5 alpha-dihydrotestosterone interact differently with the androgen receptor to enhance transcription of the MMTV-CAT reporter gene","volume":"88","author":"Deslypere","year":"1992","journal-title":"Mol. Cell. Endocrinol."},{"key":"10.1016\/j.cellsig.2016.01.013_bb0315","doi-asserted-by":"crossref","first-page":"4072","DOI":"10.1158\/1078-0432.CCR-06-0184","article-title":"Pharmacologic basis for the enhanced efficacy of dutasteride against prostatic cancers","volume":"12","author":"Xu","year":"2006","journal-title":"Clin. Cancer Res."},{"key":"10.1016\/j.cellsig.2016.01.013_bb0320","doi-asserted-by":"crossref","first-page":"307","DOI":"10.1038\/sj.pcan.4500262","article-title":"Receptor affinity and potency of non-steroidal antiandrogens: translation of preclinical findings into clinical activity","volume":"1","author":"Kolvenbag","year":"1998","journal-title":"Prostate Cancer Prostatic Dis."},{"key":"10.1016\/j.cellsig.2016.01.013_bb0325","doi-asserted-by":"crossref","first-page":"440","DOI":"10.1158\/1078-0432.CCR-1146-03","article-title":"The androgen axis in recurrent prostate cancer","volume":"10","author":"Mohler","year":"2004","journal-title":"Clin. Cancer Res."},{"key":"10.1016\/j.cellsig.2016.01.013_bb0330","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1016\/0960-0760(91)90182-5","article-title":"Regulation of growth of LNCaP human prostate tumor cells by growth factors and steroid hormones","volume":"40","author":"Schuurmans","year":"1991","journal-title":"J. Steroid Biochem. Mol. Biol."},{"key":"10.1016\/j.cellsig.2016.01.013_bb0335","doi-asserted-by":"crossref","first-page":"2393","DOI":"10.1021\/bi00123a026","article-title":"Anti-androgens and the mutated androgen receptor of LNCaP cells: differential effects on binding affinity, heat-shock protein interaction, and transcription activation","volume":"31","author":"Veldscholte","year":"1992","journal-title":"Biochemistry"},{"key":"10.1016\/j.cellsig.2016.01.013_bb0340","doi-asserted-by":"crossref","first-page":"534","DOI":"10.1016\/S0006-291X(05)80067-1","article-title":"A mutation in the ligand binding domain of the androgen receptor of human LNCaP cells affects steroid binding characteristics and response to anti-androgens","volume":"173","author":"Veldscholte","year":"1990","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"10.1016\/j.cellsig.2016.01.013_bb0345","doi-asserted-by":"crossref","first-page":"154","DOI":"10.3322\/canjclin.52.3.154","article-title":"The current state of hormonal therapy for prostate cancer","volume":"52","author":"Hellerstedt","year":"2002","journal-title":"CA Cancer J. Clin."},{"key":"10.1016\/j.cellsig.2016.01.013_bb0350","doi-asserted-by":"crossref","first-page":"9209","DOI":"10.1158\/0008-5472.CAN-04-2442","article-title":"Androgen-independent prostate cancer is a heterogeneous group of diseases: lessons from a rapid autopsy program","volume":"64","author":"Shah","year":"2004","journal-title":"Cancer Res."},{"key":"10.1016\/j.cellsig.2016.01.013_bb0355","doi-asserted-by":"crossref","first-page":"379","DOI":"10.1016\/j.critrevonc.2005.03.010","article-title":"Cancer of the prostate","volume":"56","author":"Bracarda","year":"2005","journal-title":"Crit. Rev. Oncol. Hematol."},{"key":"10.1016\/j.cellsig.2016.01.013_bb0360","doi-asserted-by":"crossref","first-page":"412","DOI":"10.1021\/cb800054w","article-title":"A cellular conformation-based screen for androgen receptor inhibitors","volume":"3","author":"Jones","year":"2008","journal-title":"ACS Chem. Biol."},{"key":"10.1016\/j.cellsig.2016.01.013_bb0365","doi-asserted-by":"crossref","first-page":"787","DOI":"10.1126\/science.1168175","article-title":"Development of a second-generation antiandrogen for treatment of advanced prostate cancer","volume":"324","author":"Tran","year":"2009","journal-title":"Science"},{"key":"10.1016\/j.cellsig.2016.01.013_bb0370","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1016\/j.jsbmb.2004.10.012","article-title":"Alterations of androgen receptor in prostate cancer","volume":"92","author":"Linja","year":"2004","journal-title":"J. Steroid Biochem. Mol. Biol."},{"key":"10.1016\/j.cellsig.2016.01.013_bb0375","first-page":"2861","article-title":"Frequent detection of codon 877 mutation in the androgen receptor gene in advanced prostate cancers","volume":"54","author":"Gaddipati","year":"1994","journal-title":"Cancer Res."},{"key":"10.1016\/j.cellsig.2016.01.013_bb0380","doi-asserted-by":"crossref","first-page":"2673","DOI":"10.1200\/JCO.2003.11.102","article-title":"Cancer, B.S. Leukemia Group, androgen receptor mutations in androgen-independent prostate cancer: Cancer and Leukemia Group B Study 9663","volume":"21","author":"Taplin","year":"2003","journal-title":"J. Clin. Oncol."},{"key":"10.1016\/j.cellsig.2016.01.013_bb0385","doi-asserted-by":"crossref","first-page":"8141","DOI":"10.1158\/0008-5472.CAN-09-0919","article-title":"Increased expression of androgen receptor sensitizes prostate cancer cells to low levels of androgens","volume":"69","author":"Waltering","year":"2009","journal-title":"Cancer Res."},{"key":"10.1016\/j.cellsig.2016.01.013_bb0390","doi-asserted-by":"crossref","first-page":"1393","DOI":"10.1056\/NEJM199505253322101","article-title":"Mutation of the androgen-receptor gene in metastatic androgen-independent prostate cancer","volume":"332","author":"Taplin","year":"1995","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.cellsig.2016.01.013_bb0395","doi-asserted-by":"crossref","first-page":"483","DOI":"10.1158\/0008-5472.CAN-12-3630","article-title":"Androgen receptor splice variants mediate enzalutamide resistance in castration-resistant prostate cancer cell lines","volume":"73","author":"Li","year":"2013","journal-title":"Cancer Res."},{"key":"10.1016\/j.cellsig.2016.01.013_bb0400","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1016\/j.jsbmb.2007.09.015","article-title":"Regulation of the adrenal androgen biosynthesis","volume":"108","author":"Rainey","year":"2008","journal-title":"J. Steroid Biochem. Mol. Biol."},{"key":"10.1016\/j.cellsig.2016.01.013_bb0405","doi-asserted-by":"crossref","first-page":"1074","DOI":"10.1016\/j.cell.2013.07.029","article-title":"A gain-of-function mutation in DHT synthesis in castration-resistant prostate cancer","volume":"154","author":"Chang","year":"2013","journal-title":"Cell"},{"key":"10.1016\/j.cellsig.2016.01.013_bb0410","doi-asserted-by":"crossref","first-page":"4365","DOI":"10.1158\/1078-0432.CCR-04-0738","article-title":"Steroid 5alpha-reductase isozymes I and II in recurrent prostate cancer","volume":"11","author":"Titus","year":"2005","journal-title":"Clin. Cancer Res."},{"key":"10.1016\/j.cellsig.2016.01.013_bb0415","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1016\/j.jsbmb.2004.10.003","article-title":"Expression and function of androgen receptor coactivators in prostate cancer","volume":"92","author":"Culig","year":"2004","journal-title":"J. Steroid Biochem. Mol. Biol."},{"key":"10.1016\/j.cellsig.2016.01.013_bb0420","doi-asserted-by":"crossref","first-page":"3422","DOI":"10.1158\/0008-5472.CAN-06-2836","article-title":"Androgen deprivation increases p300 expression in prostate cancer cells","volume":"67","author":"Heemers","year":"2007","journal-title":"Cancer Res."},{"key":"10.1016\/j.cellsig.2016.01.013_bb0425","doi-asserted-by":"crossref","first-page":"6997","DOI":"10.1073\/pnas.1304502110","article-title":"Prostate cancer-associated mutations in speckle-type POZ protein (SPOP) regulate steroid receptor coactivator 3 protein turnover","volume":"110","author":"Geng","year":"2013","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.cellsig.2016.01.013_bb0430","doi-asserted-by":"crossref","first-page":"685","DOI":"10.1038\/ng.2279","article-title":"Exome sequencing identifies recurrent SPOP, FOXA1 and MED12 mutations in prostate cancer","volume":"44","author":"Barbieri","year":"2012","journal-title":"Nat. Genet."},{"key":"10.1016\/j.cellsig.2016.01.013_bb0435","doi-asserted-by":"crossref","first-page":"347","DOI":"10.1016\/j.eururo.2012.03.050","article-title":"Exome sequencing of prostate cancer supports the hypothesis of independent tumour origins","volume":"63","author":"Lindberg","year":"2013","journal-title":"Eur. Urol."},{"key":"10.1016\/j.cellsig.2016.01.013_bb0440","doi-asserted-by":"crossref","first-page":"1632","DOI":"10.1038\/leu.2015.72","article-title":"The DEK oncoprotein and its emerging roles in gene regulation","volume":"29","author":"Sanden","year":"2015","journal-title":"Leukemia"},{"key":"10.1016\/j.cellsig.2016.01.013_bb0445","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1126\/science.1250255","article-title":"Prostate cancer. Ubiquitylome analysis identifies dysregulation of effector substrates in SPOP-mutant prostate cancer","volume":"346","author":"Theurillat","year":"2014","journal-title":"Science"},{"key":"10.1016\/j.cellsig.2016.01.013_bb0450","doi-asserted-by":"crossref","first-page":"2108","DOI":"10.1158\/0008-5472.CAN-10-1998","article-title":"Intragenic rearrangement and altered RNA splicing of the androgen receptor in a cell-based model of prostate cancer progression","volume":"71","author":"Li","year":"2011","journal-title":"Cancer Res."},{"key":"10.1016\/j.cellsig.2016.01.013_bb0455","doi-asserted-by":"crossref","first-page":"16759","DOI":"10.1073\/pnas.1012443107","article-title":"Constitutively active androgen receptor splice variants expressed in castration-resistant prostate cancer require full-length androgen receptor","volume":"107","author":"Watson","year":"2010","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.cellsig.2016.01.013_bb0460","doi-asserted-by":"crossref","first-page":"4759","DOI":"10.1038\/onc.2011.637","article-title":"AR intragenic deletions linked to androgen receptor splice variant expression and activity in models of prostate cancer progression","volume":"31","author":"Li","year":"2012","journal-title":"Oncogene"},{"key":"10.1016\/j.cellsig.2016.01.013_bb0465","doi-asserted-by":"crossref","first-page":"2305","DOI":"10.1158\/0008-5472.CAN-08-3795","article-title":"A novel androgen receptor splice variant is up-regulated during prostate cancer progression and promotes androgen depletion-resistant growth","volume":"69","author":"Guo","year":"2009","journal-title":"Cancer Res."},{"key":"10.1016\/j.cellsig.2016.01.013_bb0470","doi-asserted-by":"crossref","first-page":"e19059","DOI":"10.1371\/journal.pone.0019059","article-title":"Expression of androgen receptor splice variants in prostate cancer bone metastases is associated with castration-resistance and short survival","volume":"6","author":"Hornberg","year":"2011","journal-title":"PLoS ONE"},{"key":"10.1016\/j.cellsig.2016.01.013_bb0475","doi-asserted-by":"crossref","first-page":"e27970","DOI":"10.1371\/journal.pone.0027970","article-title":"Androgen receptor variants occur frequently in castration resistant prostate cancer metastases","volume":"6","author":"Zhang","year":"2011","journal-title":"PLoS ONE"},{"key":"10.1016\/j.cellsig.2016.01.013_bb0480","doi-asserted-by":"crossref","first-page":"339","DOI":"10.1016\/j.eururo.2013.05.012","article-title":"Words of wisdom: re: androgen receptor splice variants mediate enzalutamide resistance in castration-resistant prostate cancer cell lines","volume":"64","author":"Luo","year":"2013","journal-title":"Eur. Urol."},{"key":"10.1016\/j.cellsig.2016.01.013_bb0485","doi-asserted-by":"crossref","first-page":"392","DOI":"10.1002\/jcb.20929","article-title":"Interaction of IGF signaling and the androgen receptor in prostate cancer progression","volume":"99","author":"Wu","year":"2006","journal-title":"J. Cell. Biochem."},{"key":"10.1016\/j.cellsig.2016.01.013_bb0490","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1677\/erc.0.0090061","article-title":"Mechanisms involved in the progression of androgen-independent prostate cancers: it is not only the cancer cell's fault","volume":"9","author":"Arnold","year":"2002","journal-title":"Endocr. Relat. Cancer"},{"key":"10.1016\/j.cellsig.2016.01.013_bb0495","doi-asserted-by":"crossref","first-page":"280","DOI":"10.1038\/6495","article-title":"A mechanism for hormone-independent prostate cancer through modulation of androgen receptor signaling by the HER-2\/neu tyrosine kinase","volume":"5","author":"Craft","year":"1999","journal-title":"Nat. Med."},{"key":"10.1016\/j.cellsig.2016.01.013_bb0500","doi-asserted-by":"crossref","first-page":"729","DOI":"10.1042\/bj20020585","article-title":"Androgen receptor expression is regulated by the phosphoinositide 3-kinase\/Akt pathway in normal and tumoral epithelial cells","volume":"366","author":"Manin","year":"2002","journal-title":"Biochem. J."},{"key":"10.1016\/j.cellsig.2016.01.013_bb0505","doi-asserted-by":"crossref","first-page":"30935","DOI":"10.1074\/jbc.M201919200","article-title":"Phosphatidylinositol 3-kinase\/Akt stimulates androgen pathway through GSK3beta inhibition and nuclear beta-catenin accumulation","volume":"277","author":"Sharma","year":"2002","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.cellsig.2016.01.013_bb0510","doi-asserted-by":"crossref","first-page":"8253","DOI":"10.1200\/JCO.2005.03.4777","article-title":"Biology of progressive, castration-resistant prostate cancer: directed therapies targeting the androgen-receptor signaling axis","volume":"23","author":"Scher","year":"2005","journal-title":"J. Clin. Oncol."},{"key":"10.1016\/j.cellsig.2016.01.013_bb0515","doi-asserted-by":"crossref","first-page":"46087","DOI":"10.1074\/jbc.M306219200","article-title":"The scaffolding protein RACK1 interacts with androgen receptor and promotes cross-talk through a protein kinase C signaling pathway","volume":"278","author":"Rigas","year":"2003","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.cellsig.2016.01.013_bb0520","first-page":"3","article-title":"Nongenomic actions of steroid hormones in reproductive tissues","volume":"19","author":"Revelli","year":"1998","journal-title":"Endocr. Rev."},{"key":"10.1016\/j.cellsig.2016.01.013_bb0525","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1016\/j.yfrne.2007.10.005","article-title":"Non-genomic actions of androgens","volume":"29","author":"Foradori","year":"2008","journal-title":"Front. Neuroendocrinol."},{"key":"10.1016\/j.cellsig.2016.01.013_bb0530","doi-asserted-by":"crossref","first-page":"365","DOI":"10.1146\/annurev.physiol.59.1.365","article-title":"Specific, nongenomic actions of steroid hormones","volume":"59","author":"Wehling","year":"1997","journal-title":"Annu. Rev. Physiol."},{"key":"10.1016\/j.cellsig.2016.01.013_bb0535","doi-asserted-by":"crossref","first-page":"2181","DOI":"10.1210\/me.2002-0070","article-title":"The roles of androgen receptors and androgen-binding proteins in nongenomic androgen actions","volume":"16","author":"Heinlein","year":"2002","journal-title":"Mol. Endocrinol."},{"key":"10.1016\/j.cellsig.2016.01.013_bb0540","doi-asserted-by":"crossref","first-page":"513","DOI":"10.1016\/S0031-6997(24)01468-6","article-title":"Multiple actions of steroid hormones \u2014 a focus on rapid, nongenomic effects","volume":"52","author":"Falkenstein","year":"2000","journal-title":"Pharmacol. Rev."},{"key":"10.1016\/j.cellsig.2016.01.013_bb0545","first-page":"255","article-title":"Steroid hormone action in the neuroendocrine system: when is the genome involved?","volume":"56","author":"McEwen","year":"1978","journal-title":"Res. Publ. Assoc. Res. Nerv. Ment. Dis."},{"key":"10.1016\/j.cellsig.2016.01.013_bb0550","doi-asserted-by":"crossref","first-page":"ra48","DOI":"10.1126\/scisignal.2004911","article-title":"Nongenomic thyroid hormone signaling occurs through a plasma membrane-localized receptor","volume":"7","author":"Kalyanaraman","year":"2014","journal-title":"Sci. Signal."},{"key":"10.1016\/j.cellsig.2016.01.013_bb0555","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1016\/S1097-2765(01)00304-5","article-title":"Progesterone receptor contains a proline-rich motif that directly interacts with SH3 domains and activates c-Src family tyrosine kinases","volume":"8","author":"Boonyaratanakornkit","year":"2001","journal-title":"Mol. Cell"},{"key":"10.1016\/j.cellsig.2016.01.013_bb0560","doi-asserted-by":"crossref","first-page":"2008","DOI":"10.1093\/emboj\/17.7.2008","article-title":"Activation of the Src\/p21ras\/Erk pathway by progesterone receptor via cross-talk with estrogen receptor","volume":"17","author":"Migliaccio","year":"1998","journal-title":"EMBO J."},{"key":"10.1016\/j.cellsig.2016.01.013_bb0565","doi-asserted-by":"crossref","first-page":"5232","DOI":"10.1158\/0008-5472.CAN-04-0272","article-title":"Phosphorylation of Akt (Ser473) is an excellent predictor of poor clinical outcome in prostate cancer","volume":"64","author":"Kreisberg","year":"2004","journal-title":"Cancer Res."},{"key":"10.1016\/j.cellsig.2016.01.013_bb0570","doi-asserted-by":"crossref","first-page":"2052","DOI":"10.1210\/endo.136.5.7720654","article-title":"Androgens rapidly increase the cytosolic calcium concentration in Sertoli cells","volume":"136","author":"Gorczynska","year":"1995","journal-title":"Endocrinology"},{"key":"10.1016\/j.cellsig.2016.01.013_bb0575","doi-asserted-by":"crossref","first-page":"42992","DOI":"10.1074\/jbc.M306295200","article-title":"Activation of phosphatidylinositol 3-kinase\/Akt pathway by androgen through interaction of p85alpha, androgen receptor, and Src","volume":"278","author":"Sun","year":"2003","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.cellsig.2016.01.013_bb0580","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1016\/0014-5793(90)80762-8","article-title":"Differential regulation of prostatic protein kinase C isozymes by androgens","volume":"264","author":"Goueli","year":"1990","journal-title":"FEBS Lett."},{"key":"10.1016\/j.cellsig.2016.01.013_bb0585","doi-asserted-by":"crossref","first-page":"1639","DOI":"10.1111\/j.1471-4159.2005.03318.x","article-title":"Androgens activate mitogen-activated protein kinase signaling: role in neuroprotection","volume":"94","author":"Nguyen","year":"2005","journal-title":"J. Neurochem."},{"key":"10.1016\/j.cellsig.2016.01.013_bb0590","doi-asserted-by":"crossref","first-page":"547","DOI":"10.1083\/jcb.200211099","article-title":"Androgen-stimulated DNA synthesis and cytoskeletal changes in fibroblasts by a nontranscriptional receptor action","volume":"161","author":"Castoria","year":"2003","journal-title":"J. Cell Biol."},{"key":"10.1016\/j.cellsig.2016.01.013_bb0595","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1002\/jcp.22011","article-title":"Src signaling in cancer invasion","volume":"223","author":"Guarino","year":"2010","journal-title":"J. Cell. Physiol."},{"key":"10.1016\/j.cellsig.2016.01.013_bb0600","doi-asserted-by":"crossref","first-page":"470","DOI":"10.1038\/nrc1366","article-title":"A renaissance for SRC","volume":"4","author":"Yeatman","year":"2004","journal-title":"Nat. Rev. Cancer"},{"key":"10.1016\/j.cellsig.2016.01.013_bb0605","doi-asserted-by":"crossref","first-page":"3596","DOI":"10.1038\/sj.onc.1211016","article-title":"Src kinase potentiates androgen receptor transactivation function and invasion of androgen-independent prostate cancer C4-2 cells","volume":"27","author":"Asim","year":"2008","journal-title":"Oncogene"},{"key":"10.1016\/j.cellsig.2016.01.013_bb0610","doi-asserted-by":"crossref","first-page":"1643","DOI":"10.1073\/pnas.1120985109","article-title":"Oncogene-specific activation of tyrosine kinase networks during prostate cancer progression","volume":"109","author":"Drake","year":"2012","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.cellsig.2016.01.013_bb0615","doi-asserted-by":"crossref","first-page":"10175","DOI":"10.18632\/oncotarget.3391","article-title":"Yes-mediated phosphorylation of focal adhesion kinase at tyrosine 861 increases metastatic potential of prostate cancer cells","volume":"6","author":"Chatterji","year":"2015","journal-title":"Oncotarget"},{"key":"10.1016\/j.cellsig.2016.01.013_bb0620","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1111\/j.1464-410X.2008.08009.x","article-title":"FYN is overexpressed in human prostate cancer","volume":"103","author":"Posadas","year":"2009","journal-title":"BJU Int."},{"key":"10.1016\/j.cellsig.2016.01.013_bb0625","first-page":"5271","article-title":"Gene amplifications associated with the development of hormone-resistant prostate cancer","volume":"9","author":"Edwards","year":"2003","journal-title":"Clin. Cancer Res."},{"key":"10.1016\/j.cellsig.2016.01.013_bb0630","doi-asserted-by":"crossref","first-page":"14783","DOI":"10.1073\/pnas.192569699","article-title":"Estrogen receptor-interacting protein that modulates its nongenomic activity-crosstalk with Src\/Erk phosphorylation cascade","volume":"99","author":"Wong","year":"2002","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.cellsig.2016.01.013_bb0635","doi-asserted-by":"crossref","first-page":"1096","DOI":"10.1210\/me.2003-0335","article-title":"Characterization of the interactions of estrogen receptor and MNAR in the activation of cSrc","volume":"18","author":"Barletta","year":"2004","journal-title":"Mol. Endocrinol."},{"key":"10.1016\/j.cellsig.2016.01.013_bb0640","first-page":"719","article-title":"Nongenotropic, sex-nonspecific signaling through the estrogen or androgen receptors: dissociation from transcriptional activity","volume":"104","author":"Kousteni","year":"2001","journal-title":"Cell"},{"key":"10.1016\/j.cellsig.2016.01.013_bb0645","doi-asserted-by":"crossref","first-page":"7156","DOI":"10.1158\/0008-5472.CAN-04-1121","article-title":"Changes in androgen receptor nongenotropic signaling correlate with transition of LNCaP cells to androgen independence","volume":"64","author":"Unni","year":"2004","journal-title":"Cancer Res."},{"key":"10.1016\/j.cellsig.2016.01.013_bb0650","doi-asserted-by":"crossref","first-page":"6322","DOI":"10.1038\/sj.onc.1203032","article-title":"Rapid signalling by androgen receptor in prostate cancer cells","volume":"18","author":"Peterziel","year":"1999","journal-title":"Oncogene"},{"key":"10.1016\/j.cellsig.2016.01.013_bb0655","doi-asserted-by":"crossref","first-page":"1105","DOI":"10.1016\/j.bbamcr.2009.01.009","article-title":"Insights into Ca2+ homeostasis of advanced prostate cancer cells","volume":"1793","author":"Flourakis","year":"2009","journal-title":"Biochim. Biophys. Acta"},{"key":"10.1016\/j.cellsig.2016.01.013_bb0660","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1016\/j.neuroscience.2007.06.054","article-title":"Activation of the androgen receptor alters the intracellular calcium response to glutamate in primary hippocampal neurons and modulates sarco\/endoplasmic reticulum calcium ATPase 2 transcription","volume":"149","author":"Foradori","year":"2007","journal-title":"Neuroscience"},{"key":"10.1016\/j.cellsig.2016.01.013_bb0665","doi-asserted-by":"crossref","first-page":"90","DOI":"10.1016\/0006-291X(91)91338-D","article-title":"Effects of androgen on intracellular calcium of LNCaP cells","volume":"179","author":"Steinsapir","year":"1991","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"10.1016\/j.cellsig.2016.01.013_bb0670","doi-asserted-by":"crossref","first-page":"671","DOI":"10.2164\/jandrol.106.000554","article-title":"Androgens induce increases in intracellular calcium via a G protein-coupled receptor in LNCaP prostate cancer cells","volume":"27","author":"Sun","year":"2006","journal-title":"J. Androl."},{"key":"10.1016\/j.cellsig.2016.01.013_bb0675","doi-asserted-by":"crossref","first-page":"592","DOI":"10.1111\/bph.12307","article-title":"A novel androgen signalling pathway uses dihydrotestosterone, but not testosterone, to activate the EGF receptor signalling cascade in prostate stromal cells","volume":"170","author":"Oliver","year":"2013","journal-title":"Brit. J. Pharmacol."},{"key":"10.1016\/j.cellsig.2016.01.013_bb0680","doi-asserted-by":"crossref","first-page":"533","DOI":"10.1016\/j.steroids.2009.09.012","article-title":"Androgens are powerful non-genomic inducers of calcium sensitization in visceral smooth muscle","volume":"75","author":"Gonzalez-Montelongo","year":"2010","journal-title":"Steroids"},{"key":"10.1016\/j.cellsig.2016.01.013_bb0685","doi-asserted-by":"crossref","first-page":"733","DOI":"10.1242\/jcs.02775","article-title":"Ca2+ oscillations induced by testosterone enhance neurite outgrowth","volume":"119","author":"Estrada","year":"2006","journal-title":"J. Cell Sci."},{"key":"10.1016\/j.cellsig.2016.01.013_bb0690","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1113\/expphysiol.2012.067009","article-title":"Effects of testosterone on cardiomyocyte calcium homeostasis and contractile function in female rats","volume":"98","author":"Beesley","year":"2013","journal-title":"Exp. Physiol."},{"key":"10.1016\/j.cellsig.2016.01.013_bb0695","doi-asserted-by":"crossref","first-page":"1307","DOI":"10.4161\/cc.6.11.4353","article-title":"The complex role of AR signaling after cytotoxic insult: implications for cell-cycle-based chemotherapeutics","volume":"6","author":"Comstock","year":"2007","journal-title":"Cell Cycle"},{"key":"10.1016\/j.cellsig.2016.01.013_bb0700","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1016\/j.cell.2009.04.056","article-title":"Androgen receptor regulates a distinct transcription program in androgen-independent prostate cancer","volume":"138","author":"Wang","year":"2009","journal-title":"Cell"},{"key":"10.1016\/j.cellsig.2016.01.013_bb0705","doi-asserted-by":"crossref","first-page":"2197","DOI":"10.1038\/sj.onc.1207344","article-title":"Interleukin-8 confers androgen-independent growth and migration of LNCaP: differential effects of tyrosine kinases Src and FAK","volume":"23","author":"Lee","year":"2004","journal-title":"Oncogene"},{"key":"10.1016\/j.cellsig.2016.01.013_bb0710","doi-asserted-by":"crossref","first-page":"14579","DOI":"10.1074\/jbc.M306143200","article-title":"Androgen receptor mediates non-genomic activation of phosphatidylinositol 3-OH kinase in androgen-sensitive epithelial cells","volume":"279","author":"Baron","year":"2004","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.cellsig.2016.01.013_bb0715","doi-asserted-by":"crossref","first-page":"619","DOI":"10.1016\/S0092-8674(00)81382-3","article-title":"Serine phosphorylation of death agonist BAD in response to survival factor results in binding to 14-3-3 not BCL-X(L)","volume":"87","author":"Zha","year":"1996","journal-title":"Cell"},{"key":"10.1016\/j.cellsig.2016.01.013_bb0720","doi-asserted-by":"crossref","first-page":"766","DOI":"10.1128\/MCB.00841-10","article-title":"Phosphorylation of Trask by Src kinases inhibits integrin clustering and functions in exclusion with focal adhesion signaling","volume":"31","author":"Spassov","year":"2011","journal-title":"Mol. Cell. Biol."},{"key":"10.1016\/j.cellsig.2016.01.013_bb0725","doi-asserted-by":"crossref","first-page":"337","DOI":"10.1023\/A:1023772912750","article-title":"Src family kinases in tumor progression and metastasis","volume":"22","author":"Summy","year":"2003","journal-title":"Cancer Metastasis Rev."},{"key":"10.1016\/j.cellsig.2016.01.013_bb0730","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1016\/j.bbrc.2005.12.164","article-title":"Role of c-Src and focal adhesion kinase in progression and metastasis of estrogen receptor-positive breast cancer","volume":"341","author":"Planas-Silva","year":"2006","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"10.1016\/j.cellsig.2016.01.013_bb0735","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1016\/j.ccr.2009.05.017","article-title":"Latent bone metastasis in breast cancer tied to Src-dependent survival signals","volume":"16","author":"Zhang","year":"2009","journal-title":"Cancer Cell"},{"key":"10.1016\/j.cellsig.2016.01.013_bb0740","first-page":"5028","article-title":"C-SRC tyrosine kinase activity is associated with tumor colonization in bone and lung in an animal model of human breast cancer metastasis","volume":"63","author":"Myoui","year":"2003","journal-title":"Cancer Res."},{"key":"10.1016\/j.cellsig.2016.01.013_bb0745","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1124\/jpet.106.102004","article-title":"Inhibition of protein kinase c-Src reduces the incidence of breast cancer metastases and increases survival in mice: implications for therapy","volume":"318","author":"Rucci","year":"2006","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"10.1016\/j.cellsig.2016.01.013_bb0750","doi-asserted-by":"crossref","first-page":"9185","DOI":"10.1158\/0008-5472.CAN-05-1731","article-title":"Action of the Src family kinase inhibitor, dasatinib (BMS-354825), on human prostate cancer cells","volume":"65","author":"Nam","year":"2005","journal-title":"Cancer Res."},{"key":"10.1016\/j.cellsig.2016.01.013_bb0755","doi-asserted-by":"crossref","first-page":"1927","DOI":"10.1016\/S0959-8049(03)00394-0","article-title":"Pyrrolopyrimidine c-Src inhibitors reduce growth, adhesion, motility and invasion of prostate cancer cells in vitro","volume":"39","author":"Recchia","year":"2003","journal-title":"Eur. J. Cancer"},{"key":"10.1016\/j.cellsig.2016.01.013_bb0760","doi-asserted-by":"crossref","first-page":"1152","DOI":"10.1038\/sj.onc.1204208","article-title":"Alterations in the focal adhesion kinase\/Src signal transduction pathway correlate with increased migratory capacity of prostate carcinoma cells","volume":"20","author":"Slack","year":"2001","journal-title":"Oncogene"},{"key":"10.1016\/j.cellsig.2016.01.013_bb0765","doi-asserted-by":"crossref","first-page":"3323","DOI":"10.1158\/0008-5472.CAN-07-2997","article-title":"Targeting SRC family kinases inhibits growth and lymph node metastases of prostate cancer in an orthotopic nude mouse model","volume":"68","author":"Park","year":"2008","journal-title":"Cancer Res."},{"key":"10.1016\/j.cellsig.2016.01.013_bb0770","doi-asserted-by":"crossref","first-page":"1007","DOI":"10.1210\/me.2009-0472","article-title":"Androgens induce nongenomic stimulation of colonic contractile activity through induction of calcium sensitization and phosphorylation of LC20 and CPI-17","volume":"24","author":"Gonzalez-Montelongo","year":"2010","journal-title":"Mol. Endocrinol."},{"key":"10.1016\/j.cellsig.2016.01.013_bb0775","doi-asserted-by":"crossref","first-page":"C40","DOI":"10.1152\/ajpcell.00351.2005","article-title":"Matriptase activation and shedding with HAI-1 is induced by steroid sex hormones in human prostate cancer cells, but not in breast cancer cells","volume":"291","author":"Kiyomiya","year":"2006","journal-title":"Am. J. Physiol. Cell Physiol."},{"key":"10.1016\/j.cellsig.2016.01.013_bb0780","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1016\/j.ccr.2006.08.021","article-title":"Regulation of androgen receptor activity by tyrosine phosphorylation","volume":"10","author":"Guo","year":"2006","journal-title":"Cancer Cell"},{"key":"10.1016\/j.cellsig.2016.01.013_bb0785","first-page":"3051","article-title":"Targeting AKT\/mTOR and ERK MAPK signaling inhibits hormone-refractory prostate cancer in a preclinical mouse model","volume":"118","author":"Kinkade","year":"2008","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.cellsig.2016.01.013_bb0790","first-page":"1168","article-title":"Immunohistochemical demonstration of phospho-Akt in high Gleason grade prostate cancer","volume":"8","author":"Malik","year":"2002","journal-title":"Clin. Cancer Res."},{"key":"10.1016\/j.cellsig.2016.01.013_bb0795","doi-asserted-by":"crossref","first-page":"8351","DOI":"10.1158\/1078-0432.CCR-04-0130","article-title":"Antibody-based profiling of the phosphoinositide 3-kinase pathway in clinical prostate cancer","volume":"10","author":"Thomas","year":"2004","journal-title":"Clin. Cancer Res."},{"key":"10.1016\/j.cellsig.2016.01.013_bb0800","first-page":"1975","article-title":"Attenuation of Ras signaling restores androgen sensitivity to hormone-refractory C4-2 prostate cancer cells","volume":"63","author":"Bakin","year":"2003","journal-title":"Cancer Res."},{"key":"10.1016\/j.cellsig.2016.01.013_bb0805","doi-asserted-by":"crossref","first-page":"1878","DOI":"10.1158\/0008-5472.CAN-11-3132","article-title":"Pten loss and RAS\/MAPK activation cooperate to promote EMT and metastasis initiated from prostate cancer stem\/progenitor cells","volume":"72","author":"Mulholland","year":"2012","journal-title":"Cancer Res."},{"key":"10.1016\/j.cellsig.2016.01.013_bb0810","first-page":"986","article-title":"17-Allylamino-17-demethoxygeldanamycin induces the degradation of androgen receptor and HER-2\/neu and inhibits the growth of prostate cancer xenografts","volume":"8","author":"Solit","year":"2002","journal-title":"Clin. Cancer Res."},{"key":"10.1016\/j.cellsig.2016.01.013_bb0815","first-page":"1008","article-title":"Disruption of androgen receptor function inhibits proliferation of androgen-refractory prostate cancer cells","volume":"62","author":"Zegarra-Moro","year":"2002","journal-title":"Cancer Res."},{"key":"10.1016\/j.cellsig.2016.01.013_bb0820","doi-asserted-by":"crossref","first-page":"535","DOI":"10.1016\/j.ccr.2010.04.027","article-title":"Regression of castrate-recurrent prostate cancer by a small-molecule inhibitor of the amino-terminus domain of the androgen receptor","volume":"17","author":"Andersen","year":"2010","journal-title":"Cancer Cell"},{"key":"10.1016\/j.cellsig.2016.01.013_bb0825","doi-asserted-by":"crossref","first-page":"4947","DOI":"10.1021\/ol802021w","article-title":"Sintokamides A to E, chlorinated peptides from the sponge Dysidea sp. that inhibit transactivation of the N-terminus of the androgen receptor in prostate cancer cells","volume":"10","author":"Sadar","year":"2008","journal-title":"Organic Lett."},{"key":"10.1016\/j.cellsig.2016.01.013_bb0830","doi-asserted-by":"crossref","first-page":"503","DOI":"10.1021\/jm2014056","article-title":"Niphatenones, glycerol ethers from the sponge Niphates digitalis block androgen receptor transcriptional activity in prostate cancer cells: structure elucidation, synthesis, and biological activity","volume":"55","author":"Meimetis","year":"2012","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.cellsig.2016.01.013_bb0835","doi-asserted-by":"crossref","first-page":"384","DOI":"10.1093\/jnci\/94.5.384","article-title":"Methylation and inactivation of estrogen, progesterone, and androgen receptors in prostate cancer","volume":"94","author":"Sasaki","year":"2002","journal-title":"J. Natl. Cancer Inst."},{"key":"10.1016\/j.cellsig.2016.01.013_bb0840","doi-asserted-by":"crossref","first-page":"4037","DOI":"10.1093\/emboj\/cdf406","article-title":"Phosphorylation-dependent ubiquitylation and degradation of androgen receptor by Akt require Mdm2 E3 ligase","volume":"21","author":"Lin","year":"2002","journal-title":"EMBO J."}],"container-title":["Cellular Signalling"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0898656816300122?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0898656816300122?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,6,1]],"date-time":"2025-06-01T03:56:18Z","timestamp":1748750178000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0898656816300122"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,5]]},"references-count":168,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2016,5]]}},"alternative-id":["S0898656816300122"],"URL":"https:\/\/doi.org\/10.1016\/j.cellsig.2016.01.013","relation":{},"ISSN":["0898-6568"],"issn-type":[{"value":"0898-6568","type":"print"}],"subject":[],"published":{"date-parts":[[2016,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"The importance of non-nuclear AR signaling in prostate cancer progression and therapeutic resistance","name":"articletitle","label":"Article Title"},{"value":"Cellular Signalling","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.cellsig.2016.01.013","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2016 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}